Singapore markets open in 1 hour 50 minutes
Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,018.39 -17.30 (-0.34%) Dow
37,903.29 +87.37 (+0.23%) Nasdaq
15,605.48 -52.34 (-0.33%) Bitcoin USD
57,806.46 -2,622.40 (-4.34%) CMC Crypto 200
1,272.68 -66.39 (-4.96%)
Lonza Group AG (LZAGF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 02:32PM EDT
| Previous close | 560.00 |
| Open | 567.41 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 537.04 - 570.90 |
| 52-week range | 336.03 - 661.60 |
| Volume | |
| Avg. volume | 962 |
| Market cap | 38.744B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | 55.42 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 4.57 (0.82%) |
| Ex-dividend date | 13 May 2024 |
| 1y target est | N/A |
- Business Wire
Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies
BOSTON & BASEL, Switzerland, June 26, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Lonza (SIX: LONN) today announced a strategic collaboration to support the manufacture of Vertex’s portfolio of investigational stem cell-derived, fully differentiated insulin-producing islet cell therapies for people with T1D, currently focusing on the VX-880 and VX-264 programs that are currently in clinical trials.
© 2024 Yahoo. All rights reserved.